New Zealand markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
209.39-1.37 (-0.65%)
At close: 04:00PM EDT
214.50 +5.11 (+2.44%)
After hours: 07:04PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts19192320
Avg. Estimate-1.78-1.7-7.29-4.32
Low estimate-2.33-2.96-9.41-8.03
High estimate-1.250.24-3.220.89
Year ago EPS-1.72-2.16-7.2-7.29
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts18182424
Avg. Estimate293.14M334.73M1.07B1.62B
Low estimate246.65M300M1B1.31B
High estimate327.8M403.35M1.12B2.13B
Year ago sales218.69M258.54M844.29M1.07B
Sales growth (year/est)34.00%29.50%27.10%50.60%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-1.57-1.54-1.84-1.63
Actual EPS-1.72-2.16-2-2.29
Difference-0.15-0.62-0.16-0.66
Surprise %-9.60%-40.30%-8.70%-40.50%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-1.78-1.7-7.29-4.32
7 days ago-1.78-1.7-7.29-4.35
30 days ago-1.78-1.7-7.46-4.31
60 days ago-1.72-1.7-7.07-3.54
90 days ago-1.69-1.69-6.86-3.37
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A2N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.-3.50%N/AN/AN/A
Next qtr.21.30%N/AN/AN/A
Current year-1.20%N/AN/AN/A
Next year40.70%N/AN/AN/A
Next 5 years (per annum)-177.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A